PRDM1 expression is often silenced in activated-B-cell-like (ABC)-DLBCL by multiple genetic and epigenetic mechanisms15,16, which prevents the terminal differentiation and increases the proliferative capacity of B cells14. This evidence concerns the gene PRDM1 and diffuse large B-cell lymphoma.